Risperdal
Payments companies reported to CMS as associated with Risperdal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Risperdal, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Risperdal
These are the largest totals companies reported as associated with Risperdal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Bogoyas | Yakima, WA | Psychiatry | $565.06 |
| Brenda Acosta | Yakima, WA | Psychiatric/Mental Health (Nurse Practitioner) | $341.74 |
| Dennis Gaither | Mount Vernon, WA | Psychiatry | $327.42 |
| Angela Kokinakos | Everett, WA | Psychiatric/Mental Health (Nurse Practitioner) | $241.98 |
| Ka Chan | Yakima, WA | Psychiatric/Mental Health (Nurse Practitioner) | $241.60 |
| Jeffrey Berger | Mount Vernon, WA | Psychiatry | $219.12 |
| May Dee Gemilo | Everett, WA | Psychiatric/Mental Health (Nurse Practitioner) | $204.78 |
| Hamayun Ahmed | Lehighton, PA | Psychiatry | $197.50 |
| Gagandeep Mundi | Lynnwood, WA | Psychiatric/Mental Health (Nurse Practitioner) | $192.68 |
| Jana Robison | Everett, WA | Psychiatric/Mental Health (Nurse Practitioner) | $188.59 |
Prescribed Risperdal?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.